TABLE 2

Whole-Body 18F-FDG PET Scan Results

Disease statusResult of baseline studyResult of follow-up study
MGUS14/14 (100%) negative; followed 3–43+ moIn 1/14 (7%), myeloma developed at 8 mo; in 1 patient, focal plasmacytoma with amyloid developed*
Active myeloma16/16 (100%) positive; 4/16 (25%) had negative radiography results but multiple focal lesions on scanIn 1 patient, disease was upstaged from stage I to III: Multiple new disease sites were identified
4/16 (25%) had extramedullary diseasePoor outcome with extramedullary disease
RemissionIn 6/10 (60%), new lesions developed over 6–42+ moLocal irradiation used for focal relapse; nonsecretory relapse detected and treated
Relapse21/26 (81%) had new sites of diseaseAnatomic distribution of lesions documented
6/26 (23%) had extramedullary diseaseVery poor survival with extramedullary disease: median, 7 mo